We are live on ! Find out more
OBCI

Ocean Bio-Chem Inc

Delisted

OBCI was delisted on the 8th of August, 2022.

18 hedge funds and large institutions have $6.64M invested in Ocean Bio-Chem Inc in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less funds holding

Funds holding: 2118 (-3)

17% less capital invested

Capital invested by funds: $8.02M → $6.64M (-$1.39M)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
18
Holders Change
-3
Holders Change %
-14.29%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
7
Closed
5
Calls
Puts
Net Calls
Net Calls Change

OBCI Hedge Fund Activity: Q4 2021 in Review

18 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Ocean Bio-Chem Inc (OBCI) for Q4 2021, worth a combined $6.64M — down 17% from $8.02M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of OBCI and 2 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 4 added.

The largest buyer was Stifel Financial, adding an estimated $31.6K. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $334K sold.

  • 18 institutional investors held Ocean Bio-Chem Inc (OBCI) as of Q4 2021, down from 21 in Q3 2021.
  • Funds reported $6.64M of Ocean Bio-Chem Inc stock for Q4 2021, down 17% quarter-over-quarter.
  • 2 funds opened new Ocean Bio-Chem Inc positions in Q4 2021 and 5 closed out, a net change of -3 holders.
  • The largest Ocean Bio-Chem Inc buyer in Q4 2021 was Stifel Financial, an estimated $31.6K added.
  • The largest Ocean Bio-Chem Inc seller in Q4 2021 was Bank of New York Mellon, an estimated $334K sold.

Based on aggregated 13F filings for Q4 2021.